Re: Resverlogix and Zenith Special Meetings
|
4
|
Resverlogix Corp.
|
Jul 01, 2015 11:42AM
|
Re: BIO Investor Forum, Oct 22-23
|
4
|
Resverlogix Corp.
|
Oct 21, 2019 08:42PM
|
Re: My cynical nature....
|
4
|
Resverlogix Corp.
|
Jul 08, 2015 08:53AM
|
Re: Hump Day Fun
|
4
|
Resverlogix Corp.
|
Mar 30, 2023 12:03PM
|
Re: is anyone thinking or expecting any movement in the sp or
|
4
|
Resverlogix Corp.
|
Jan 06, 2016 10:41AM
|
Re: At least RVX has a shorter trial timeline than ESPR
|
4
|
Resverlogix Corp.
|
May 05, 2016 08:01PM
|
Re: Apabetalone Inhibits SARS-CoV-2 Infection at Levels Comparable to Approved Antiviral
|
4
|
Resverlogix Corp.
|
Mar 15, 2021 11:02AM
|
Re: Merrill Lynch
|
4
|
Resverlogix Corp.
|
Jun 09, 2020 06:04PM
|
Re: Anyone else find it odd......
|
4
|
Resverlogix Corp.
|
Aug 19, 2019 04:56PM
|
Re: Web replay of Yale Presentation from NYC...
|
4
|
Resverlogix Corp.
|
Sep 29, 2015 06:21PM
|
Qatar Research overview of apabetalone
|
4
|
Resverlogix Corp.
|
Apr 23, 2024 08:38PM
|
Re: Hail Mary
|
4
|
Resverlogix Corp.
|
Dec 13, 2023 11:39AM
|
Re: Zenith Epigenetics and China-Based Newsoara Biopharma Announce Licensing Agreement for ZEN-3694
|
4
|
Zenith Epigenetics
|
Aug 07, 2019 11:20AM
|
Re: Stock Alert
|
4
|
Resverlogix Corp.
|
Feb 11, 2018 04:19PM
|
Re: Reply from Sarah
|
4
|
Zenith Epigenetics
|
Dec 12, 2015 08:56AM
|
Re: Optimistic
|
4
|
Resverlogix Corp.
|
Oct 19, 2021 10:37AM
|
Re: Reply from Sarah
|
4
|
Zenith Epigenetics
|
Dec 12, 2015 10:07AM
|
Re: Resverlogix announces HEPALINK debenture $6mill
|
4
|
Resverlogix Corp.
|
May 05, 2021 11:07AM
|
Prostate Cancer News Today Article
|
4
|
Zenith Epigenetics
|
Jul 03, 2019 01:07PM
|
Re: DSMB 7th review??
|
4
|
Resverlogix Corp.
|
Jul 20, 2018 04:40PM
|